Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA337592
Max Phase: Preclinical
Molecular Formula: C11H11N3O
Molecular Weight: 201.23
Molecule Type: Small molecule
Associated Items:
ID: ALA337592
Max Phase: Preclinical
Molecular Formula: C11H11N3O
Molecular Weight: 201.23
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N#Cc1[nH]c2ccc(O)cc2c1CCN
Standard InChI: InChI=1S/C11H11N3O/c12-4-3-8-9-5-7(15)1-2-10(9)14-11(8)6-13/h1-2,5,14-15H,3-4,12H2
Standard InChI Key: YXXOHKFHHPGTPN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 201.23 | Molecular Weight (Monoisotopic): 201.0902 | AlogP: 1.25 | #Rotatable Bonds: 2 |
Polar Surface Area: 85.83 | Molecular Species: BASE | HBA: 3 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.99 | CX Basic pKa: 9.81 | CX LogP: 0.13 | CX LogD: -1.10 |
Aromatic Rings: 2 | Heavy Atoms: 15 | QED Weighted: 0.68 | Np Likeness Score: 0.11 |
1. Blum E, Buchheit K, Buescher H, Gamse R, Kloeppner E, Meigel H, Papageorgiou C, Waelchli R, Revesz L. (1992) Design and synthesis of novel ligands for the 5-HT3 and the 5-HT4 receptor, 2 (5): [10.1016/S0960-894X(00)80170-5] |
Source(1):